USPTO serial 97088951
GENERATE LIFE SCIENCES
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- GALBO, AMANDA
- Law office
- TMO LAW OFFICE 125
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with GENERATE LIFE SCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Los Angeles, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gregory N. Owen
Gregory N. Owen Owen, Wickersham & Erickson, P.C.2300 Clayton Road, Suite 1400One Concord CenterConcord, CA 94520Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | (Based on Intent to Use) Pharmaceutical preparations for the treatment of female and male fertility and infertility; (Based on Use in Commerce) Cryopreservation devices provided with and without remote tracking capabilities in the nature of vitrification and thawing media kits for use with in vitro fertilization consisting primarily of vitrification and thawing solutions, specially coated petri dishes in the nature of vitrification dishes, and vitrification devices for cryogenic storage of oocytes and embryos | ACTIVE | Dec 31, 2020 |
| 009 | (Based on Intent To Use) Downloadable software and mobile application for the delivery of test content and interpretations for clinical testing, and for the exchange of genetic information and genetic test results | ACTIVE | — |
| 010 | (Based on Use in Commerce) Medical equipment, namely, a vitrification kit for use with in vitro fertilization for oocytes, embryos or other biological cells, comprising vitrification devices and synthetic media, namely, specially coated petri dishes in the nature of vitrification dishes, vitrification and thawing solutions, and vitrification devices for cryogenic storage of oocytes and embryos; medical equipment, namely, catheter parts in the nature of stylets for intrauterine insemination catheters, intrauterine insemination catheters used for the insemination of sperm, needles for medical use; all of the foregoing provided with and without remote tracking capabilities | ACTIVE | Dec 31, 2020 |
| 035 | (Based on Use in Commerce) Wholesale distributorships featuring medical equipment; retail store services and online retail store services featuring medical equipment | ACTIVE | Dec 31, 2020 |
| 042 | (Based on Use in Commerce) Medical and scientific research and development in the field of pharmaceuticals, infectious diseases, genetics, genomics, fertility, biologic testing and interpretation, cellular therapies, immune diseases, ancestry analysis; providing temporary use of a web based software platform for storing, accessing, evaluating, and analyzing patients' bio-specimens, genetic information, and genetic test results; genetic testing for scientific research purposes; providing electronic genetic data storage and providing analysis in the field of genetic testing for scientific research and clinical research purposes for the health care industry; providing temporary use of a web based software platform for bioinformatics analysis for medical and diagnostic purposes; scientific analysis services, namely, DNA and medical record analysis services for scientific research and clinical research purposes for the health care industry; providing temporary use of a web-based software platform for the delivery of test content and interpretations for clinical testing, and for the exchange of genetic information and genetic test results | ACTIVE | Dec 31, 2020 |
| 044 | (Based on Use in Commerce) Collection and preservation of human placenta and placental tissue for scientific research and medical purposes in the fields of pharmaceuticals, infectious diseases, genetics, genomics, fertility, biologic testing and interpretation, cellular therapies, immune diseases; Medical testing services, namely, genetic testing services related to carrier screening, DNA extraction, polygenic risk assessment, pharmacogenomic testing; cardio risk assessment, stem cells, DNA analysis and profiling | ACTIVE | Dec 31, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Generate IP Holdings LLC
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GENERATE LIFE SCIENCES
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 8, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 24, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 8, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 9, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 11, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 13, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 12, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 4, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 20, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 20, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 20, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 20, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 4, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 4, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 4, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 2, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 2, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2021 | NWAP | NEW APPLICATION ENTERED | — |